A few cases of thyroid eye disease following alemtuzumab therapy have been described in patients with multiple sclerosis. Our patient is the first case of Graves' orbitopathy after alemtuzumab conditioning for hematopoietic stem cell transplantation.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930230 | PMC |
| http://dx.doi.org/10.1002/ccr3.1486 | DOI Listing |
Publication Analysis
Top Keywords
graves' orbitopathy
8
orbitopathy allogeneic
4
allogeneic bone
4
bone marrow
4
marrow transplantation
4
transplantation patient
4
patient fanconi
4
fanconi anemia
4
anemia side
4
side alemtuzumab
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!